Logo image
Extracorporeal life support in the new millennium: Forging ahead or fading out?
Journal article

Extracorporeal life support in the new millennium: Forging ahead or fading out?

New Horizons: Science and Practice of Acute Medicine, Vol.7(3)
1999

Abstract

heparin anticoagulant therapy bleeding cardiopulmonary bypass cardiopulmonary insufficiency diuresis extracorporeal oxygenation hospital infection human iatrogenic disease lung injury nutrition patient selection pediatrics priority journal respiratory distress syndrome Review sedation survival rate treatment outcome
Extracorporeal membrane oxygenation (ECMO), a modified form of cardiopulmonary bypass, has been used in almost 20,000 patients with cardiorespiratory failure. It provides temporary life support and has a survival rate of 70%. This article will focus on the current state of the art in pediatric ECMO for respiratory failure. Patient selection criteria, modes of ECMO support, patient management techniques, complications, and outcome will be presented. The future of ECMO in relation to current treatment of respiratory failure as well as its use in alternative patient populations will be outlined.

Metrics

5 Record Views

Details

Logo image